Karen L. Smith

Global Head of R&D and CMO, Jazz Pharmaceuticals.

Companies

Context Therapeutics Inc.Board member Sep 5, 2024 to now¹
Skye Bioscience, Inc.Board member Jul 5, 2024 to now²
SANGAMO THERAPEUTICS, INCBoard member Jun 28, 2018 to now³
Aurinia Pharmaceuticals Inc.Board member Aug 21, 2023 to Nov 25, 2024⁴
Tourmaline Bio, Inc.Board member May 17, 2022 to Jun 14, 2023⁵
IRulya Therapeutics Inc.Chief Medical Officer May 23, 2022 to Feb 2, 2023⁶
ANTARES PHARMA, INC.Board member Mar 5, 2019 to May 26, 2022⁷
Acceleron PharmaBoard member Nov 15, 2017 to Nov 22, 2021⁸
Emergent BioSolutionsEVP, Chief Medical Officer May 28, 2020 to May 11, 2021⁹
Jazz PharmaceuticalsGlobal Head of R&D and CMO Apr 23, 2015 to Mar 7, 2018¹⁰
Sucampo PharmaceuticalsBoard member Jul 27, 2017 to Feb 13, 2018¹¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 12, 2025Granted 25,000 shares of SANGAMO THERAPEUTICS, INC¹⁴
Nov 21, 2024Granted 12,135 shares of Aurinia Pharmaceuticals Inc.¹³
Nov 11, 2024Sold 5,241 shares at $8.43 of Aurinia Pharmaceuticals Inc.¹⁷
Nov 8, 2024Exercised options 17,913 shares of Aurinia Pharmaceuticals Inc.¹⁷
Jun 4, 2024Granted 25,000 shares of SANGAMO THERAPEUTICS, INC¹⁸
Jun 1, 2023Granted 13,900 shares of SANGAMO THERAPEUTICS, INC¹⁹
May 24, 2022Returned to company 25,452 shares at $5.60 of ANTARES PHARMA, INC.¹⁵
May 24, 2022Returned to company 54,193 shares at $5.60 of ANTARES PHARMA, INC.¹⁵
May 19, 2022Granted 170,354 shares of IRulya Therapeutics Inc.¹²
May 19, 2022Granted 24,336 shares of IRulya Therapeutics Inc.²⁰
Feb 25, 2022Granted 12,500 shares of SANGAMO THERAPEUTICS, INC²¹
Nov 19, 2021U 1,622 shares of Acceleron Pharma¹⁶

The numbers on this page point here. Each one links to the record it came from.